|
US5239084A
(en)
|
1990-06-29 |
1993-08-24 |
Hoffmann-La Roche Inc. |
Substituted aminoalkyl biphenyl compounds
|
|
US5827868A
(en)
|
1991-10-07 |
1998-10-27 |
E. R. Squibb & Sons, Inc. |
Prostaglandin analogs
|
|
US5565485A
(en)
|
1993-03-19 |
1996-10-15 |
Merck & Co., Inc. |
Biphenyl compounds useful or endothelin antagonists
|
|
US5334598A
(en)
|
1993-03-19 |
1994-08-02 |
Merck & Co., Inc. |
Six-membered ring fused imidazoles substituted with phenoxyphenylacetic acid derivatives
|
|
US5391566A
(en)
|
1993-07-20 |
1995-02-21 |
Merck & Co., Inc. |
Benzimidazolinones substituted with phenoxyphenylacetic acid derivatives
|
|
DE19601782A1
(de)
|
1996-01-19 |
1997-07-24 |
Merck Patent Gmbh |
Chinolin-2-(1H)one
|
|
CO4960662A1
(es)
*
|
1997-08-28 |
2000-09-25 |
Novartis Ag |
Ciertos acidos 5-alquil-2-arilaminofenilaceticos y sus derivados
|
|
WO1999065867A1
(en)
|
1998-06-17 |
1999-12-23 |
Du Pont Pharmaceuticals Company |
Cyclic hydroxamic acids as metalloproteinase inhibitors
|
|
US6617351B1
(en)
|
1998-07-31 |
2003-09-09 |
Eli Lilly And Company |
Amide, carbamate, and urea derivatives
|
|
NZ515087A
(en)
|
1999-04-28 |
2003-11-28 |
Aventis Pharma Gmbh |
Tri-aryl acid derivatives as PPAR receptor ligands
|
|
DE19937537A1
(de)
|
1999-08-09 |
2001-03-08 |
Gruenenthal Gmbh |
Substituierte 2-Dialkylaminoalkylbiphenyl-Derivate
|
|
ATE315230T1
(de)
|
1999-08-23 |
2006-02-15 |
Bml Inc |
Verfahren zum identifizieren von prostaglandin d2 rezeptor modulatoren
|
|
US20010047027A1
(en)
|
2000-04-12 |
2001-11-29 |
Marc Labelle |
Prostaglandin D2 receptor antagonists
|
|
US6878522B2
(en)
|
2000-07-07 |
2005-04-12 |
Baiyong Li |
Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2
|
|
DE60215000T2
(de)
|
2001-05-23 |
2007-08-09 |
Merck Frosst Canada & Co, Kirkland |
Dihydropyrroloil[1,2-a]indol- und Tetrahydropyridol[1,2-a]indol-Derivate als Prostaglandin-D2-Rezeptor-Antagonisten
|
|
WO2003006670A2
(en)
|
2001-07-09 |
2003-01-23 |
Axys Pharmaceuticals, Inc. |
2-[5-(5-carbamimidoyl-1h-heteroaryl)-6-hydroxybiphenyl-3-yl]-succinic acid derivatives as factor viia inhibitors
|
|
IL160845A0
(en)
*
|
2001-09-14 |
2004-08-31 |
Tularik Inc |
Linked biaryl compounds
|
|
EP1558614B1
(en)
|
2002-10-30 |
2010-09-01 |
Merck Frosst Canada Ltd. |
Pyridopyrrolizine and pyridoindolizine derivatives
|
|
JP2004182657A
(ja)
|
2002-12-04 |
2004-07-02 |
Eisai Co Ltd |
Ｈｄｌレベル上昇促進剤
|
|
ES2401079T3
(es)
*
|
2002-12-20 |
2013-04-16 |
Amgen Inc. |
Moduladores del asma y de la inflamación alérgica
|
|
DE60303238T2
(de)
|
2003-04-25 |
2006-09-14 |
Actimis Pharmaceuticals, Inc., La Jolla |
Pyrimidin-Essigsäure Derivate geeignet zur Behandlung von CRTH2-bedingten Krankheiten
|
|
JP2007508363A
(ja)
|
2003-10-14 |
2007-04-05 |
オキサジェン リミテッド |
Ｃｒｔｈ２アンタゴニスト活性を有する化合物
|
|
GB0324763D0
(en)
|
2003-10-23 |
2003-11-26 |
Oxagen Ltd |
Use of compounds in therapy
|
|
US8008525B2
(en)
|
2003-11-26 |
2011-08-30 |
Takeda Pharmaceutical Company Limited |
Receptor function regulating agent
|
|
US7019022B2
(en)
|
2003-12-15 |
2006-03-28 |
Merck Frosst Canada & Co. |
Substituted tetrahydrocarbazole and cyclopentanoindole derivatives
|
|
CN1942428A
(zh)
|
2004-04-13 |
2007-04-04 |
默克公司 |
Cetp抑制剂
|
|
GB0409921D0
(en)
|
2004-05-04 |
2004-06-09 |
Novartis Ag |
Organic compounds
|
|
GB0415320D0
(en)
*
|
2004-07-08 |
2004-08-11 |
Astrazeneca Ab |
Novel compounds
|
|
MX2007001943A
(es)
|
2004-08-17 |
2007-05-09 |
Galderma Res & Dev |
Nuevos compuestos biaromaticos activadores de los receptores del tipo receptor activado del proliferador de peroxisoma (ppar) y su uso en composiciones cosmeticas o farmaceuticas.
|
|
BRPI0515532A
(pt)
|
2004-09-21 |
2008-07-29 |
Athersys Inc |
composto, composição farmacêutica, métodos de inibir a ligação de ligandos endógenos ao receptor de crth-2 em uma célula, de tratar, melhorar ou prevenir um distúrbio responsivo à inibição da ligação de ligandos endógenos ao receptor de crt-2 e de preparar um composto, e, kit
|
|
KR20070115865A
(ko)
|
2004-09-21 |
2007-12-06 |
아더시스 인코포레이티드 |
Ｃｒｔｈ2 수용체 길항작용을 나타내는 벤즈이미다졸아세트산 및 이의 용도
|
|
US20070299122A1
(en)
|
2004-11-08 |
2007-12-27 |
Tobert Jonathan A |
Method of Treating Pathological Blushing
|
|
AP2007003980A0
(en)
|
2004-11-23 |
2007-06-30 |
Pfizer Prod Inc |
Dibenzylamine compounds and derivatives
|
|
GB0510584D0
(en)
|
2005-05-24 |
2005-06-29 |
Novartis Ag |
Organic compounds
|
|
GB0518783D0
(en)
|
2005-09-14 |
2005-10-26 |
Argenta Discovery Ltd |
Indolizine compounds
|
|
RU2405770C2
(ru)
|
2005-09-27 |
2010-12-10 |
Сионоги Энд Ко., Лтд. |
Производное сульфонамида, обладающее антагонистической активностью в отношении рецептора pgd2
|
|
EP1937632A1
(en)
|
2005-10-06 |
2008-07-02 |
Astra Zeneca AB |
Novel compounds
|
|
ES2380683T3
(es)
*
|
2005-12-15 |
2012-05-17 |
Astrazeneca Ab |
Difenil-éteres, -amidas, -sulfuros y - metanos sustituidos para el tratamiento de la enfermedad respiratoria
|
|
EP3205644A1
(en)
|
2005-12-29 |
2017-08-16 |
Celtaxsys Inc. |
Diamine derivatives as inhibitors of leukotriene a4 hydrolase
|
|
JP2009539881A
(ja)
*
|
2006-06-09 |
2009-11-19 |
アイコス コーポレイション |
Ｄｐ−２アンタゴニストとしての置換フェニル酢酸
|
|
ES2396715T3
(es)
*
|
2006-08-21 |
2013-02-25 |
Array Biopharma, Inc. |
Derivados de ácido fenoxifenilacético 4-sustituido
|
|
CA2691987C
(en)
|
2007-06-12 |
2016-08-16 |
Achaogen, Inc. |
Antibacterial agents
|
|
RU2010103104A
(ru)
|
2007-07-02 |
2011-08-10 |
Ф.Хоффманн-Ля Рош Аг (Ch) |
Производные имидазола в качестве антагонистов рецептора ccr2
|
|
MX2010003621A
(es)
|
2007-10-01 |
2010-04-14 |
Hoffmann La Roche |
N-heterociclil biaril carboxamidas como antagonistas del receptor ccr.
|
|
GB0719521D0
(en)
|
2007-10-05 |
2007-11-14 |
Argenta Discovery Ltd |
Compounds
|
|
GB0722216D0
(en)
|
2007-11-13 |
2007-12-27 |
Oxagen Ltd |
Use of crth2 antagonist compounds
|
|
GB0722203D0
(en)
|
2007-11-13 |
2007-12-19 |
Oxagen Ltd |
Use of CRTH2 antagonist compounds
|
|
DK2250161T3
(da)
|
2008-01-18 |
2014-01-27 |
Atopix Therapeutics Ltd |
Forbindelser med CRTH2-antagonistaktivitet
|
|
EP2245002A4
(en)
|
2008-02-01 |
2011-08-17 |
Amira Pharmaceuticals Inc |
AMINOALKYLBIPHENYL ANTAGONISTS N, N 'DISUBSTITUTED FROM D2 RECEPTORS OF PROSTAGLANDIN
|
|
US8067445B2
(en)
|
2008-02-01 |
2011-11-29 |
Panmira Pharmaceuticals, Llc |
N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors
|
|
EP2257536A4
(en)
|
2008-02-14 |
2011-03-23 |
Amira Pharmaceuticals Inc |
CYCLIC DIARYL ETHERS AS ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS
|
|
US8426449B2
(en)
|
2008-04-02 |
2013-04-23 |
Panmira Pharmaceuticals, Llc |
Aminoalkylphenyl antagonists of prostaglandin D2 receptors
|
|
MX2010014172A
(es)
*
|
2008-07-03 |
2011-02-22 |
Amira Pharmaceuticals Inc |
Antagonistas de receptores de prostaglandina d2.
|
|
WO2010039977A2
(en)
|
2008-10-01 |
2010-04-08 |
Amira Pharmaceuticals, Inc. |
Heteroaryl antagonists of prostaglandin d2 receptors
|
|
US8524748B2
(en)
|
2008-10-08 |
2013-09-03 |
Panmira Pharmaceuticals, Llc |
Heteroalkyl biphenyl antagonists of prostaglandin D2 receptors
|
|
US8383654B2
(en)
|
2008-11-17 |
2013-02-26 |
Panmira Pharmaceuticals, Llc |
Heterocyclic antagonists of prostaglandin D2 receptors
|
|
US20100173313A1
(en)
|
2009-01-08 |
2010-07-08 |
Amira Pharmaceuticals, Inc. |
Biomarkers of inflammation
|
|
WO2011014587A2
(en)
|
2009-07-31 |
2011-02-03 |
Amira Pharmaceuticals, Inc. |
Ophthalmic pharmaceutical compositions of dp2 receptor antagonists
|
|
JP2013500979A
(ja)
|
2009-07-31 |
2013-01-10 |
パンミラ ファーマシューティカルズ，エルエルシー． |
Ｄｐ２受容体アンタゴニストの皮膚用製剤
|